Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 10, 2018

Primary Completion Date

July 20, 2022

Study Completion Date

July 20, 2022

Conditions
MesotheliomaPeritoneal Mesothelioma
Interventions
DIAGNOSTIC_TEST

HR-MRI

The first 5 patients will undergo HR-MRI scans using different sequence parameters. Results in these patients will then be assessed along with standard CT Imaging to determine which sequences appear to best identify peritoneal disease. The optimal HR-MRI sequences will then be used for the next 19 patients in the Testing phase to formally define their performance compared to standard imaging.

DIAGNOSTIC_TEST

Standard CT Imaging

Standard CT scans will be performed for preoperative imaging in all patients.

DIAGNOSTIC_TEST

Ultrasound

Ultrasound Elastography will be performed using an FDA-Approved diagnostic GE ultrasound scanner

Trial Locations (1)

60637

University Of Chicago Medicine Comprehensive Cancer Center, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT03867578 - Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma | Biotech Hunter | Biotech Hunter